• Fund Type: Closed-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

H&Q Healthcare Investors

+ Add to Watchlist

HQH:US

28.1100 USD 0.5180 1.81%

As of 20:04:01 ET on 09/22/2014.

Snapshot for H&Q Healthcare Investors (HQH)

Open: 28.5200 High - Low: 28.5700 - 28.0200 Primary Exchange: New York
Volume: 84,745 52-Week Range: 21.6500 - 31.3517 Beta vs BTK: 0.8013

ETF Chart for HQH

No chart data available.
  • HQH:US 28.1100
  • 1D
  • 1M
  • 1Y
28.6280
Interactive HQH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for HQH

H&Q Healthcare Investors is a diversified, closed-end management investment company incorporated in the USA. The Trust's objective seeks long-term capital appreciation. The Trust will invest 80% of its assets in health services and medical technology companies, that have significant potential for above-average growth.

Inception Date: 1987-04-22 Telephone: 1-617-772-8500
Managers: DANIEL R OMSTEAD
Web Site: www.teklacap.com

Fundamentals for HQH

NAV (on 2014-09-22) 29.0000
Assets (M) (on 2014-09-22) 1,029.1040
Shares out (M) 35.48
Market Cap (M) 997.38
% Premium -3.07
Average 52-Week % Premium -1.4956
Fund Leveraged N

Dividends for HQH

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-08-27) 0.5600
Dividend Yield (ttm) 7.47%

Performance for HQH

1-Month +1.61% 1-Year +28.24%
3-Month +12.54% 3-Year +38.76%
Year To Date +14.30% 5-Year +29.90%
Expense Ratio 1.26

Top Fund Holdings for HQH

Filing Date: 12/31/2013
Name Position Value % of Total
Gilead Sciences Inc 1,039,942 78,151,641 10.619%
Celgene Corp 706,182 59,658,255 8.106%
Regeneron Pharmaceuticals Inc 178,740 49,196,398 6.685%
Biogen Idec Inc 132,195 36,981,551 5.025%
Alexion Pharmaceuticals Inc 259,405 34,516,429 4.690%
Amgen Inc 286,769 32,737,549 4.448%
Actavis plc 158,892 26,693,856 3.627%
Vertex Pharmaceuticals Inc 346,735 25,762,411 3.501%
Perrigo Co PLC 154,896 23,770,340 3.230%
iShares Nasdaq Biotechnology E 97,826 22,212,372 3.018%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil